Please assess the completion status of the following clinical trial:

Trial Title: Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* The child had been enrolled in the initial phase of the trial of seasonal vaccination with the RTS,S/AS01 vaccine~* A parent or legally recognised guardian provides informed consent for the child's inclusion in the extension study~* The child is a permanent resident of the study area and likely to remain a resident for the duration of the trial~The child is under five years of age at the time of enrolment.~Exclusion Criteria:~* The child has had an allergic reaction to the study drugs or vaccines~* The child had febrile convulsions on more than one occasion following vaccination~* The child has developed a serious underlying illness such as severe malnutrition (weight for age or mid arm circumference Z scores \< 3 SD) which in view of the investigators might impair the response to vaccination~* The child has been enrolled in another malaria vaccine or other experimental malaria intervention study

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- SMC with SP+AQ (Type: ACTIVE_COMPARATOR): Administration of tetanus/diphtheria toxoids vaccine followed by 4 cycles of SMC with sulphadoxine/pyrimethamine plus amodiaquine in Year 1 and 2.
- RTS,S/AS01 (Type: ACTIVE_COMPARATOR): Administration of the malaria vaccine RTS,S/AS01 followed by 4 cycles of SMC with placebo in Year 1 and 2.
- RTS,S/AS01 plus SMC with SP+AQ (Type: ACTIVE_COMPARATOR): Administration of the malaria vaccine RTS,S/AS01 followed by 4 cycles of SMC with sulphadoxine/pyrimethamine plus amodiaquine in Year 1 and 2.

Based on this trial design, predict the completion outcome and termination type (if applicable).